Praxis Precision Medicines, Inc. (PRAX) stock
PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$328.13+3.37 (+1.04%)
Close on Nov 13, 2026Market cap $9.16BP/E –Yield –
Praxis Precision Medicines enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Praxis Precision Medicines's enterprise value was $8.27B on Nov 11, 2026, against $3.77B a year earlier. Over the last 5 years it ranged from -$111.01M to $8.38B, with a median of $383.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.27B | +41.3% |
| 2025 | Dec 31, 2025 | $5.85B | +510.8% |
| 2024 | Dec 31, 2024 | $957.59M | +965.8% |
| 2023 | Dec 29, 2023 | $89.85M | – |
| 2022 | Dec 30, 2022 | -$12.21M | -102.2% |
| 2021 | Dec 31, 2021 | $567.80M | – |
| 2020 | Dec 31, 2020 | -$22.73M | – |
See a number that looks wrong?